News
Lilly’s appeal of an earlier, negative recommendation from a key EMA committee has worked out in its favor, and puts the drug ...
Oklahoma Sen. Markwayne Mullin (R) on Thursday objected to a Democratic resolution demanding the Department of Justice ...
Earlier versions of a spending cuts package targeted PEPFAR, the popular global AIDS relief program. The White House agreed to spare the program to avoid defections, and the spending cuts passed the ...
Note that some links may require registration or subscription. A New York man who entered an MRI room while a scan was taking ...
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
Two Republican senators and a broad bipartisan coalition of funders and nonprofits prevented a 600% increase in taxes levied ...
The move reveals both the power of philanthropic groups to sway legislators and a split in the administration’s coalition.
SYRACUSE — At last year’s inaugural “Famous Hoosiers” program Richard Gunderman made a moving and very well received presentation about Hoosier legend John Wooden.
Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities reiterated its “Buy” rating on Eli Lilly stock.
Shares of Eli Lilly & Co. LLY slid 2.47% to $775.45 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.52% to 6,173.07 ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.
Meanwhile, Lilly is notching win after win. Eli Lilly's position in the weight management market makes its stock attractive, considering how fast this area is projected to grow in the coming years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results